NLRP3 and amyotrophic lateral sclerosis: Increased levels of NLRP3, ASC, IL-18 and caspase-1 have been observed not only in animal models, but also in human patients with ALS [106, 109, 110].Therefore, NLRP3 inflammasome may become a potential target for intervention of neuronal death.